STOCK TITAN
  1. Home
  2. Financials
  3. ANEB
  4. Net Income

Anebulo Pharmaceuticals Inc (ANEB) Net Income by Year

ANEB

Anebulo Pharmaceuticals Inc reported a net loss of $8.5M in fiscal year 2025. This represents a decrease of 3.5% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters Anebulo Pharmaceuticals Inc has filed alongside them.

FY2025 annual
Net Income -$8.5M
YoY -3.5%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ANEB Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-K
Net Income-$8.5M-3.5%-$8.2M+30.1%-$11.7M-71.9%-$6.8M+77.4%-$30.3M

ANEB Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$2.0M+18.8%-$2.2M+1.9%N/A-$1.7M-1.4%-$2.5M+9.4%-$2.2M+11.3%N/A-$1.7M+40.9%-$2.7M+29.0%-$2.5M+5.0%N/A-$2.8M-49.1%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Anebulo Pharmaceuticals Inc financials

Frequently Asked Questions

What was Anebulo Pharmaceuticals Inc's net income in fiscal year 2025?

Anebulo Pharmaceuticals Inc reported a net loss of $8.5M in fiscal year 2025.

How fast is Anebulo Pharmaceuticals Inc's net income growing?

Anebulo Pharmaceuticals Inc (ANEB) net income fell by 3.5% year over year, from -$8.2M to -$8.5M in fiscal year 2025.

How has Anebulo Pharmaceuticals Inc's net income changed over the years?

Across the 5 fiscal years this page covers, Anebulo Pharmaceuticals Inc (ANEB) net income went from -$30.3M in fiscal year 2021 to -$8.5M in fiscal year 2025.

Anebulo Pharmaceuticals Inc (ANEB) reported -$2.0M in net income in Q2 2026. This represents an increase of 18.8% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Anebulo Pharmaceuticals Inc (ANEB) reported on that line in every period on record.